The effect of aprotinin on outcome after coronary-artery bypass grafting. Shaw AD, Stafford-Smith M, White WD, Phillips-Bute B, Swaminathan M, Milano C, Welsby IJ, Aronson S, Mathew JP, Peterson ED, Newman MF (2008) N Engl J Med 358: 784-93 The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. Califf RM, Harrell FE, Lee KL, Rankin JS, Hlatky MA, Mark DB, Jones RH, Muhlbaier LH, Oldham HN, Pryor DB (1989) JAMA 261: 2077-86 The changing survival benefits of coronary revascularization over time. Pryor DB, Harrell FE, Rankin JS, Lee KL, Muhlbaier LH, Oldham HN, Hlatky MA, Mark DB, Reves JG, Califf RM (1987) Circulation 76: V13-21 Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Bounous EP, Mark DB, Pollock BG, Hlatky MA, Harrell FE, Lee KL, Rankin JS, Wechsler AS, Pryor DB, Califf RM (1988) Circulation 78: I151-7 Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease. 20 years of follow-up. Muhlbaier LH, Pryor DB, Rankin JS, Smith LR, Mark DB, Jones RH, Glower DD, Harrell FE, Lee KL, Califf RM (1992) Circulation 86: II198-204 Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Smith LR, Harrell FE, Rankin JS, Califf RM, Pryor DB, Muhlbaier LH, Lee KL, Mark DB, Jones RH, Oldham HN (1991) Circulation 84: III245-53 Problems and advantages of an observational data base approach to evaluating the effect of therapy on outcome. Rosati RA, Lee KL, Califf RM, Pryor DB, Harrell FE (1982) Circulation 65: 27-32 Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass. Pretorius M, Murphey LJ, McFarlane JA, Vaughan DE, Brown NJ (2003) Circulation 108: 3079-83 Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Mark DB, Nelson CL, Califf RM, Harrell FE, Lee KL, Jones RH, Fortin DF, Stack RS, Glower DD, Smith LR (1994) Circulation 89: 2015-25 Current prognosis of ischemic mitral regurgitation. Implications for future management. Hickey MS, Smith LR, Muhlbaier LH, Harrell FE, Reves JG, Hinohara T, Califf RM, Pryor DB, Rankin JS (1988) Circulation 78: I51-9 Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass. Pretorius M, Donahue BS, Yu C, Greelish JP, Roden DM, Brown NJ (2007) Circulation 116: I1-7 Acute pulmonary embolectomy: a contemporary approach. Aklog L, Williams CS, Byrne JG, Goldhaber SZ (2002) Circulation 105: 1416-9 Survival of coronary artery disease patients with stable pain and normal left ventricular function treated medically or surgically at Duke University. Whalen RE, Harrell FE, Lee KL, Rosati RA (1982) Circulation 65: 49-52 Factor V Leiden protects against blood loss and transfusion after cardiac surgery. Donahue BS, Gailani D, Higgins MS, Drinkwater DC, George AL (2003) Circulation 107: 1003-8 Changing efficacy of coronary revascularization. Implications for patient selection. Califf RM, Harrell FE, Lee KL, Rankin JS, Mark DB, Hlatky MA, Muhlbaier LH, Wechsler AS, Jones RH, Oldham HN (1988) Circulation 78: I185-91 Randomized trials of coronary artery bypass surgery: impact on clinical practice at Duke University Medical Center. Califf RM, Hlatky MA, Mark DB, Lee KL, Harrell FE, Rosati RA, Pryor DB (1985) Circulation 72: V136-44 Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. Hlatky MA, Califf RM, Harrell FE, Lee KL, Mark DB, Pryor DB (1988) J Am Coll Cardiol 11: 237-45 Emergency coronary artery bypass surgery for percutaneous coronary interventions: changes in the incidence, clinical characteristics, and indications from 1979 to 2003. Yang EH, Gumina RJ, Lennon RJ, Holmes DR, Rihal CS, Singh M (2005) J Am Coll Cardiol 46: 2004-9 Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Fabbrini E, Tamboli RA, Magkos F, Marks-Shulman PA, Eckhauser AW, Richards WO, Klein S, Abumrad NN (2010) Gastroenterology 139: 448-55 Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgery. Light RW, Rogers JT, Moyers JP, Lee YC, Rodriguez RM, Alford WC, Ball SK, Burrus GR, Coltharp WH, Glassford DM, Hoff SJ, Lea JW, Nesbitt JC, Petracek MR, Starkey TD, Stoney WS, Tedder M (2002) Am J Respir Crit Care Med 166: 1567-71 Bile acids and bariatric surgery. Albaugh VL, Banan B, Ajouz H, Abumrad NN, Flynn CR (2017) Mol Aspects Med 56: 75-89 Changes in B-type natriuretic peptide and BMI following Roux-en-Y gastric bypass surgery. Marney AM, Brown NJ, Tamboli R, Abumrad N (2014) Diabetes Care 37: e70-1 Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy. Dunn JP, Abumrad NN, Breitman I, Marks-Shulman PA, Flynn CR, Jabbour K, Feurer ID, Tamboli RA (2012) Diabetes Care 35: 137-42 The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Isbell JM, Tamboli RA, Hansen EN, Saliba J, Dunn JP, Phillips SE, Marks-Shulman PA, Abumrad NN (2010) Diabetes Care 33: 1438-42 Effects of proximal gut bypass on glucose tolerance and insulin sensitivity in humans. Breitman I, Isbell JM, Saliba J, Jabbour K, Flynn CR, Marks-Shulman PA, Laferrère B, Abumrad NN, Tamboli RA (2013) Diabetes Care 36: e57 Contribution of endogenous bradykinin to fibrinolysis, inflammation, and blood product transfusion following cardiac surgery: a randomized clinical trial. Balaguer JM, Yu C, Byrne JG, Ball SK, Petracek MR, Brown NJ, Pretorius M (2013) Clin Pharmacol Ther 93: 326-34 A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass. Pretorius M, Scholl FG, McFarlane JA, Murphey LJ, Brown NJ (2005) Clin Pharmacol Ther 78: 477-85 Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypass. Pretorius M, McFarlane JA, Vaughan DE, Brown NJ, Murphey LJ (2004) Clin Pharmacol Ther 76: 379-87 Comparative effects of angiotensin receptor blockade and ACE inhibition on the fibrinolytic and inflammatory responses to cardiopulmonary bypass. Billings FT, Balaguer JM, C Y, Wright P, Petracek MR, Byrne JG, Brown NJ, Pretorius M (2012) Clin Pharmacol Ther 91: 1065-73 Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis. Zhang XL, Zhu QQ, Yang JJ, Chen YH, Li Y, Zhu SH, Xie J, Wang L, Kang LN, Xu B (2017) BMC Med 15: 84 Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery. Hatoum IJ, Stylopoulos N, Vanhoose AM, Boyd KL, Yin DP, Ellacott KL, Ma LL, Blaszczyk K, Keogh JM, Cone RD, Farooqi IS, Kaplan LM (2012) J Clin Endocrinol Metab 97: E1023-31 Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids. Albaugh VL, Flynn CR, Cai S, Xiao Y, Tamboli RA, Abumrad NN (2015) J Clin Endocrinol Metab 100: E1225-33 P-selectin 1087G/A polymorphism is associated with neuropsychological test performance in older adults with cardiovascular disease. Gunstad J, Benitez A, Hoth KF, Spitznagel MB, McCaffery J, McGeary J, Kakos LS, Poppas A, Paul RH, Jefferson AL, Sweet LH, Cohen RA (2009) Stroke 40: 2969-72 Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. Swaminathan M, Shaw AD, Phillips-Bute BG, McGugan-Clark PL, Archer LE, Talbert S, Milano CA, Patel UD, Stafford-Smith M (2007) Crit Care Med 35: 2286-91 Symptomatic persistent post-coronary artery bypass graft pleural effusions requiring operative treatment : clinical and histologic features. Lee YC, Vaz MA, Ely KA, McDonald EC, Thompson PJ, Nesbitt JC, Light RW (2001) Chest 119: 795-800 Eotaxin-3 and interleukin-5 pleural fluid levels are associated with pleural fluid eosinophilia in post-coronary artery bypass grafting pleural effusions. Kalomenidis I, Stathopoulos GT, Barnette R, Guo Y, Peebles RS, Blackwell TS, Light RW (2005) Chest 127: 2094-100 Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery. Dudley RA, Harrell FE, Smith LR, Mark DB, Califf RM, Pryor DB, Glower D, Lipscomb J, Hlatky M (1993) J Clin Epidemiol 46: 261-71 Agreement of self-reported comorbid conditions with medical and physician reports varied by disease among end-stage renal disease patients. Merkin SS, Cavanaugh K, Longenecker JC, Fink NE, Levey AS, Powe NR (2007) J Clin Epidemiol 60: 634-42 Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Billings FT, Ball SK, Roberts LJ, Pretorius M (2011) Free Radic Biol Med 50: 1480-7
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.